实验室安全性和免疫性评估活体减弱禽传染性支气管炎GI-23病毒疫苗

Walid H Kilany1, Mohamed A Zain El-Abideen2, Islam Hisham1

  • 1Reference Laboratory for Veterinary Quality Control on Poultry Production (RLQP), Animal Health Research Institute (AHRI), Agricultural Research Center (ARC), P.O. Box 264, Dokki, Giza 12618, Egypt; MEVAC - Middle East for Vaccines, Second Industrial Area, El-Salihya El-Gededa, El-Sharkia 44813, Egypt.

Vaccine
|December 25, 2024
PubMed
概括

一种新型活体减弱病毒疫苗显示出保护免受禽传染性支气管炎 (IBV) 病原体GI-23变种菌株的潜力. 该疫苗是安全的,不会恢复毒性,并提供有效的免疫力对IBV.